Lawrence Epstein - 15 Jun 2022 Form 4 Insider Report for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN)

Reporting relationship: Director
Issuer ticker: ADN
Reported as of: 15 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jun 2022, 19:55:08 UTC
Prior SEC filing: 18 Apr 2022
Source filing: View source filing
Reporting owner signature: /s/ Lawrence Epstein

Key filing fact

Lawrence Epstein filed Form 4 for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN) on 17 Jun 2022.

Key facts

This page summarizes Lawrence Epstein's Form 4 filing for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Jun 2022, 19:55.

Change

Previous filing in this sequence was filed on 18 Apr 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ADN transaction

Common Stock

Award

Transaction value: $0
Shares: +64,516
Change %: +2081%
Price: $0.000000
Shares after: 67,616
Date: 15 Jun 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Restricted stock units ("RSUs") granted pursuant to Issuer's 2021 Equity Incentive Plan as part of Reporting Person's compensation for service as a director of Issuer. The RSUs represent a contingent right to receive common stock of Issuer upon vesting. The RSUs vest 100% on either June 8, 2023, which is the first anniversary of the vesting commencement date, or as of the 2023 annual meeting of stockholders of Issuer, whichever is earlier.